Smoke-derived nitric oxide and vascular prostacyclin are unable to counteract the platelet effect of increased thromboxane formation in healthy female smokers

Clinical Physiology

Volumn 16, Issue 3, 1996, Pages 301-315

  Rangemark C ^a   Wennmalm, Åke ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiovascular diseases; Endothelium derived factors; Nucleotides; Platelets; Prostaglandins; Smoking

Indexed keywords

ANTITHROMBOCYTIC AGENT; CIGARETTE SMOKE; CREATININE; CYCLIC AMP; CYCLIC GMP; NITRIC OXIDE; PROSTACYCLIN; THROMBOXANE; THROMBOXANE A2; THROMBOXANE B2;

ADULT; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; CREATININE CLEARANCE; CREATININE URINE LEVEL; CYCLIC AMP BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; INCIDENCE; METABOLITE; NORMAL HUMAN; PRIORITY JOURNAL; SECOND MESSENGER; SEX DIFFERENCE; SMOKE; THROMBOCYTOPOIESIS; URINARY EXCRETION;

EID: 0029892672     PISSN: 01445979     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1475-097x.1996.tb00576.x     Document Type: Article

References (48)

1. ABBOTT R. D., YIN Y., REE D. M. & YANO K. (1986) Risk of stroke in male cigarette smokers. N Engl J Med, 315, 717-720.
2. ALVING K., FORNHEM C. & LUNDBERG J. M. (1993) Pulmonary effects of endogenous and exogenous nitric oxide in the pig: relation to cigarette smoke inhalation. Br J Pharmacol, 110, 739-746.
3. ARNOLD W. P., ALDRED R. & MURAD F (1977) Cigarette smoke activates guanylate cyclase and increases guanosine 3, 5-monophosphate in tissues. Science, 198, 934-936.
4. BARROW S. E., WARD P. S., SLEIGHTHOLM M. A., RITTER J. M. & DOLLERY C. T. (1989) Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine. Biochim Biophys Acta, 993, 121-127.
5. BERMAN A. M. (1989) Facts on women and smoking. JAMWA, 44, 55-59.
6. BIRNBAUMER L. & BROWN A. M. (1990) G proteins and the mechanism of action of hormones, neurotransmitters and autocrine and paracrine regulatory factors. Am Rev Respir Dis, 141, S106-S114.
7. DAVIES M. J. & THOMAS A. T. (1984) Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med, 310, 1137-1140.
8. DOLL R. & HILL A. B. (1964) Mortality in relation to smoking: ten years observations of British doctors. Br Med J, 248, 1399-1410.
9. DOLL R., GRAY R., HAFNER B. & PETO R. (1980) Mortality in relation to smoking; 22 years observation on female British doctors. Br Med J, 280, 967-971.
10. 2 formation without affecting platelet survival in young healthy females. Thrombosis Hemost, 68, 583-588.
11. DOYLE J. T., DAWBER T. R., KANNEL W. B., HESLIN A. S. & KAHN H. A. (1962) Cigarette smoking and coronary heart disease. Combined experience of the Albany and Framingham studies. N Engl J Med, 266, 796-801.
12. FIELDING J. E. (1987) Smoking and women. Tragedy of the majority. N Engl J Med, 317, 1343-1345.
13. FISCHER S., BERNUTZ C., MEIER H. & WEBER P. C. (1986) Formation of prostacyclin and thromboxane in man as measured by the main urinary metabolites. Biochim Biophys Acta, 876, 194-199.
14. GORDON T., KANNEL W. B., MCGEE D. & DAWBER T. R. (1974) Death and coronary attacks in men after giving up cigarette smoking: a report from the Framingham Study. Lancet, 2, 1345-1348.
15. 15N]nitrate in biological fluids. Anal Biochem, 126, 131-138.
16. GRUETTER C. A., BARRY B. K., MCNAMARA D. B., KADOWITZ P. J. & IGNARRO L. J. (1980) Coronary arterial relaxation and guanylate cyclase activation by cigarette smoke, N′-nitrosonornicotine and nitric oxide. J Pharmacol Exp Ther, 214, 9-15.
17. HABIB F., DUDKA D., CROSSMAN D., OAKLEY C. M. & CLELAND J. G. F. (1994) Enhanced basal nitric oxide production in heart failure: another failed counterregulatory vasodilator mechanism? Lancet, 344, 371-373.
18. HAMBERG M., SVENSSON J. & SAMUELSSON B. (1975) Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA, 72, 2994-2998.
19. HIBBS JR J. B., WESTENFELDER C., TAINTOR R., VAVRIN Z., KABLITZ C., BARANOWSKI R. L., WARD J. H., MENLOVE R. J., MCMURRY M. P., KUSHNER J. P. & SAMLOWSKI W. E. (1992) Evidence for cytokine-in-ducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest, 89, 867-877.
20. HÖGMAN M., FROSTELL C., ARNBERG H. & HEDENSTIERNA G. (1993) Bleeding time prolongation and NO inhalation. Lancet, 341, 1664-1665.
21. HOURANI S. M. O. & CUSACK N. J. (1991) Pharmacological receptors on blood platelets. Pharmacological Reviews, 43, 243-298.
22. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988): Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction; ISIS2. Lancet, 2, 349-360.
23. JUNGERSTEN L., EDLUND A., HAFSTRÖM L. O., KARLSSON L., PETERSSON A. S. & WENNMALM Å. (1993a) Plasma nitrate as an index of immune system activation in animals and man. J Clin Lab Immunol, 40, 1-4.
24. JUNGERSTEN L., EDLUND A., PETERSSON A. S. & WENNMALM Å. (1993b) Plasma nitrate as an index of endogenous nitric oxide formation in man. Analysis of kinetics, confounding factors, and response to immunological challenge. Circulation, 88, 1-369.
25. KANNEL W. B. (1981) Update of the role of cigarette smoking in coronary artery disease. Am Heart J, 101, 319-328.
26. LERNER D. J. & KANNEL W. B. (1986) Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow up of the Framingham population. Am Heart J, 111, 383-390.
27. MACLENNAN S. J., BOLOFO M. L. & MARTIN G. R. (1993) Amplifying interactions between spasmogens in vascular smooth muscle. Biochem Soc Trans, 21, 1145-1150.
28. MANN J. I., DOLL R., THOROGOOD M., VESSEY M. P. & WATERS W. E. (1976) Risk factors for myocardial infarction in young women. Br J Prev Soc Med, 30, 94-100.
29. MURRAY R., SHIPP E., FITZGERALD G. A. (1990) Prostaglandin endoperoxide/thromboxane A2 receptor desensitization. Cross-talk with adenylate cyclase in human platelets. J Biol Chem, 265, 21670-21675.
30. NORMAN V. & KEITH C. H. (1965) Nitrogen oxides in tobacco smoke. Nature, 205, 915-916.
31. NOWAK J., MURRAY J. J., OATES J. A. & FITZGERALD G. A. (1987) Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation, 76, 6-14.
32. PERLMAN J. A., WOLF P. H., RAY R. & LIEBERKNECHT G. (1988) Cardiovascular risk factors, premature heart disease and all-cause mortality in a cohort of Northern California women. Am J Obstet Gynecol, 158, 1568-1574.
33. RADOMSKI M. W., PALMER R. M. J. & MONCADA S. (1990) An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA, 87, 5193-5197.
34. RÅNGEMARK C. & WENNMALM Å. (1991) Cigarette smoking and urinary excretion of markers for platelet/vessel wall interaction in healthy women. Clin Science, 81, 11-15.
35. RÅNGEMARK C., BENTHIN G., GRANSTRÖM E. F., PERSSON L., WINELL S. & WENNMALM Å. (1992) Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age. Circulation, 86, 1495-1500.
36. RÅNGEMARK C., CIABATTONI G. & WENNMALM Å. (1993) Excretion of thromboxane metabolites in healthy women after cessation of smoking. Arterioscter Thromb, 13, 777-782.
37. REILLY I. A. G. & FITZGERALD G. A. (1986) Eicosenoid biosynthesis and platelet function with advancing age. Thromb Res, 41, 545-554.
38. ROBERTS II L. J., SWEETMAN B. J. & OATES J. A. (1981) Metabolism of thromboxane B2 in man. J Biol Chem, 256, 8384-8393.
39. ROSENBERG L., KAUFMAN D. W., HELMRICH S. P., MILLER D. R., STOLLEY P. D. & SHAPIRO S. (1985) Myocardial infarction and cigarette smoking in women younger than 50 years of age. JAMA, 253, 2965-2969.
40. ROSENBERG L., PALMER J. R. & SHAPIRO S. (1990) Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med, 322, 213-217.
41. Ross R. (1986) The pathogenesis of atherosclerosis: An update. N Engl J Med, 314, 488-500.
42. ROSSAINT R., FALKE K. J., LOFEZ F., SLAMA K., PISON U. & ZAPOL W. M. (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med, 328, 399-405.
43. SPAIN D. M., SIEGEL H. & BRADESS V. A. (1973) Women smokers and sudden death: The relationship of cigarette smoking to coronary disease. JAMA, 224, 1005-1007.
44. STEERING COMMITTEE ON THE PHYSICIANS HEALTH STUDY RESEARCH GROUP (1989) Final report on the aspirin components of the ongoing Physicians Health Study. N Engl J Med, 321, 129-135.
45. 51Cr-labelled platelets: a comparative study using both stored and fresh platelets. Br J Haematol, 78, 523-528.
46. WENNMALM Å., BENTHIN G., GRANSTRÖM E. F., PERSSON L., PETERSSON A. S. & WINELL S. (1991) Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men. Circulation, 83, 1698-1704.
47. WENNMALM Å., BENTHIN G., EDLUND A., JUNGERSTEN L., KIELER-JENSEN N., LUNDIN S., NATHORST WESTFELT U., PETERSSON A. S. & WAAGSTEIN F. (1993) Metabolism and excretion of nitric oxide in humans; an experimental and clinical study. Circ Res, 73, 1121-1127.
48. WINLAW D. S., SMYTHE G. A., KEOGH A. M., SCHYVENS C. G., SPRATT P. M. & MACDONALD P. S. (1994) Increased nitric oxide in heart failure. Lancet, 344, 373-374.